Research

Main navigation

Researchers at The Neuro are world leaders in cellular and molecular neuroscience, brain imaging, cognitive neuroscience and the study and treatment of neurological diseases and disorders. Here are their stories.

Finding the master switch for ALS

27 Jun 2024

A new clinical trial is testing existing medication that could slow the progression of the disease.

Read more about Finding the master switch for ALS

Crossing the blood-brain barrier to treat MS

18 Jun 2024

A clinical trial at The Neuro is targeting immune cells deep in the brain to slow disease progression.

Read more about Crossing the blood-brain barrier to treat MS

Clinician-scientist awarded prestigious ALS fellowship

18 Jun 2024

The 2024 Fellow is Dr. Matti Allen, a clinician-scientist in neuromuscular medicine.

Read more about Clinician-scientist awarded prestigious ALS fellowship

A new Open Science tool for studying ALS breathing failure 

10 Jun 2024

Protocol might also be used to study other motor neuron diseases, including spinal muscular atrophy and Kennedy’s disease. 

Read more about A new Open Science tool for studying ALS breathing failure

Making progress against MS progression

28 May 2024

Researchers have developed drugs that improve the outlook for millions of patients.

Read more about Making progress against MS progression

On the hunt for a treatment

25 Apr 2024

The Neuro is launching its first ever clinical trials for Huntington’s Disease.

Read more about On the hunt for a treatment

A more effective means to detect and treat epileptic seizures

15 Apr 2024

Dr. Jeffrey Hall’s research is refining epilepsy surgery to create lesions that permanently disrupt seizures.

Read more about A more effective means to detect and treat epileptic seizures

Supporting the next generation of autism researchers

5 Apr 2024

The Quebec Autism Research Training program is a competitive program offered by the Azrieli Centre for Autism Research and the Transforming Autism Care Consortium.

Read more about Supporting the next generation of autism researchers

Repressing a faulty gene

18 Mar 2024

A study underway at The Neuro is the first in Canada to evaluate whether a treatment using an antisense oligonucleotide therapy would be effective against Creutzfeldt-Jakob Disease.

Read more about Repressing a faulty gene

Pages

Be inspired

Neuro XXceptional stories

I Choose The Neuro stories

The Neuro logo

The Neuro (Montreal Neurological Institute-Hospital) is a bilingual academic healthcare institution. We are a McGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.